West Pharmaceutical Services
West Pharmaceutical Services, Inc., commonly referred to as West, is a leading provider of innovative solutions for injectable drug delivery and containment. Headquartered in the United States, West operates extensively across major regions, including Europe and Asia, serving a global clientele in the pharmaceutical and biotechnology industries. Founded in 1923, the company has achieved significant milestones, including advancements in drug delivery systems and the development of high-quality packaging solutions. West's core offerings include a range of primary packaging components, delivery systems, and contract manufacturing services, all designed to enhance the safety and efficacy of medications. What sets West apart is its commitment to quality and innovation, ensuring that its products meet the stringent demands of the healthcare sector. With a strong market position and a reputation for excellence, West continues to be a trusted partner for pharmaceutical companies worldwide.
DitchCarbon Score
How does West Pharmaceutical Services's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
West Pharmaceutical Services's score of 28 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
West Pharmaceutical Services's reported carbon emissions
In 2023, West Pharmaceutical Services reported total Scope 1 and 2 emissions of approximately 104,190,000 kg CO2e. This marks a significant reduction from previous years, with total emissions of about 128,234,000 kg CO2e in 2021 and 122,934,000 kg CO2e in 2022. The company has set ambitious targets to further reduce its carbon footprint, aiming for a 40% reduction in absolute emissions for both Scope 1 and Scope 2 by 2030, starting from 2022 levels. West Pharmaceutical Services is committed to enhancing its sustainability efforts, which include achieving 50% renewable electricity and improving energy efficiency by 3% annually. The company has demonstrated a consistent focus on reducing its greenhouse gas emissions, with a GHG emissions intensity of approximately 2,430 kg CO2e per million USD in revenue reported for 2023. Overall, West Pharmaceutical Services is actively working towards its climate commitments, reflecting a strong dedication to environmental responsibility within the pharmaceutical and biotechnology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 26,493,000 | 00,000,000 | 00,000,000 | - |
| Scope 2 | 118,057,000 | - | - | - |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
West Pharmaceutical Services is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
